Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Townsend

Showing results (381-390 of 395) with videos related to

Pageof 40
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMabel Seto, Hannah M Klinger, Vaibhav A Janve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 29, 2024
Latent change-on-change between amyloid accumulation and cognitive declineHannah M Klinger, Brian C Healy, Bernard J Hanseeuw, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2026
Elevated temporal tau PET predicts faster cognitive decline in women than men: A meta-analysisAnnie Li, Hannah M Klinger, Mabel Seto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisHannah M Klinger, Vaibhav A Janve, Mabel Seto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnnie Li, Hannah M Klinger, Mabel Seto, et al.
Emerging Infectious Diseases|April 30, 2025
Powassan and Eastern Equine Encephalitis Virus Seroprevalence in Endemic Areas, United States, 2019-2020Hannah Padda, Claire Y-H Huang, Kacie Grimm, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Nature Medicine|August 15, 2025
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trialFlorian Eichler, Oguz I Cataltepe, Rrita Daci, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
Pageof 40

Showing results (381-390 of 395) with videos related to

Sort By:
Pageof 40
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisMabel Seto, Hannah M Klinger, Vaibhav A Janve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 29, 2024
Latent change-on-change between amyloid accumulation and cognitive declineHannah M Klinger, Brian C Healy, Bernard J Hanseeuw, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2026
Elevated temporal tau PET predicts faster cognitive decline in women than men: A meta-analysisAnnie Li, Hannah M Klinger, Mabel Seto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisHannah M Klinger, Vaibhav A Janve, Mabel Seto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnnie Li, Hannah M Klinger, Mabel Seto, et al.
Emerging Infectious Diseases|April 30, 2025
Powassan and Eastern Equine Encephalitis Virus Seroprevalence in Endemic Areas, United States, 2019-2020Hannah Padda, Claire Y-H Huang, Kacie Grimm, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Nature Medicine|August 15, 2025
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trialFlorian Eichler, Oguz I Cataltepe, Rrita Daci, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
Pageof 40